Nearly 50 years after the “war on cancer” was declared in the United States, precision medicine is changing the face of cancer research.
Advances in how the immune system can be harnessed to fight cancer offer new hope to patients with lung cancer.
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care.
The drug Gleevec is well known not only for its effectiveness against leukemia. A similar drug might be able to tame some brain cancers, new research from Columbia University Medical Center has shown.
Two Columbia University Medical Center faculty members were present today when President Obama provided details of the precision medicine initiative he announced during this year’s State of the Union address.